Search Results

There are 3119 results for: content related to: Cost-effectiveness of bazedoxifene compared with raloxifene in the treatment of postmenopausal osteoporotic women

  1. You have free access to this content
    Effects of bazedoxifene on bone mineral density, bone turnover, and safety in postmenopausal japanese women with osteoporosis

    Journal of Bone and Mineral Research

    Volume 26, Issue 3, March 2011, Pages: 519–529, Akira Itabashi, Kousei Yoh, Arkadi A Chines, Takami Miki, Masahiko Takada, Hiroshi Sato, Itsuo Gorai, Toshitsugu Sugimoto, Hideki Mizunuma, Hiroshi Ochi, Ginger D Constantine and Hiroaki Ohta

    Version of Record online : 18 FEB 2011, DOI: 10.1002/jbmr.252

  2. You have free access to this content
    Effects of Bazedoxifene on BMD and Bone Turnover in Postmenopausal Women: 2-Yr Results of a Randomized, Double-Blind, Placebo-, and Active-Controlled Study

    Journal of Bone and Mineral Research

    Volume 23, Issue 4, April 2008, Pages: 525–535, Paul D Miller, Arkadi A Chines, Claus Christiansen, Hans C Hoeck, David L Kendler, E Michael Lewiecki, Grattan Woodson, Amy B Levine, Ginger Constantine and Pierre D Delmas

    Version of Record online : 10 DEC 2007, DOI: 10.1359/jbmr.071206

  3. You have free access to this content
    Efficacy of Bazedoxifene in Reducing New Vertebral Fracture Risk in Postmenopausal Women With Osteoporosis: Results From a 3-Year, Randomized, Placebo-, and Active-Controlled Clinical Trial

    Journal of Bone and Mineral Research

    Volume 23, Issue 12, December 2008, Pages: 1923–1934, Stuart L Silverman, Claus Christiansen, Harry K Genant, Slobodan Vukicevic, José R Zanchetta, Tobie J de Villiers, Ginger D Constantine and Arkadi A Chines

    Version of Record online : 28 JUL 2008, DOI: 10.1359/jbmr.080710

  4. Evolution of Selective Estrogen and Androgen Receptor Modulators: Status of Current Therapy and New Drug Development

    Standard Article

    Pharmaceutical Sciences Encyclopedia

    Gregory T. Wurz and Michael W. DeGregorio

    Published Online : 16 DEC 2011, DOI: 10.1002/9780470571224.pse462

  5. You have free access to this content
    Hormone therapy for sexual function in perimenopausal and postmenopausal women

    Intervention Review

    The Cochrane Library

    Carolina O Nastri, Lucia A Lara, Rui A Ferriani, Ana Carolina JS Rosa-e-Silva, Jaqueline BP Figueiredo and Wellington P Martins

    Published Online : 5 JUN 2013, DOI: 10.1002/14651858.CD009672.pub2

  6. Advances in menopausal therapy: The tissue-selective estrogen complex

    Journal of the American Academy of Nurse Practitioners

    Volume 25, Issue 3, March 2013, Pages: 126–133, Anne Moore

    Version of Record online : 26 NOV 2012, DOI: 10.1111/j.1745-7599.2012.00804.x

  7. A double-blind, randomized, ascending, multiple-dose study of bazedoxifene in healthy postmenopausal women

    Clinical Pharmacology in Drug Development

    Volume 3, Issue 4, July/August 2014, Pages: 262–269, William E. McKeand, Gayle P. Orczyk, James C. Ermer and Arkadi A. Chines

    Version of Record online : 9 FEB 2014, DOI: 10.1002/cpdd.102

  8. Bazedoxifene and Conjugated Equine Estrogen: A Combination Product for the Management of Vasomotor Symptoms and Osteoporosis Prevention Associated with Menopause

    Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy

    Volume 36, Issue 5, May 2016, Pages: 548–561, Elena M. Umland, Lauren Karel and Nanette Santoro

    Version of Record online : 11 MAY 2016, DOI: 10.1002/phar.1749

  9. Osteoporosis Therapy: Mechanistic Antiresorptives

    Standard Article

    Burger's Medicinal Chemistry and Drug Discovery

    Jeffrey A. Dodge and Henry U. Bryant

    Published Online : 29 JAN 2010, DOI: 10.1002/0471266949.bmc197

  10. Selective estrogen receptor modulators protect hippocampal neurons from kainic acid excitotoxicity: Differences with the effect of estradiol

    Journal of Neurobiology

    Volume 61, Issue 2, November 2004, Pages: 209–221, Iratxe Ciriza, Paloma Carrero, Iñigo Azcoitia, Scott G. Lundeen and Luis M. Garcia-Segura

    Version of Record online : 6 JUL 2004, DOI: 10.1002/neu.20043

  11. Carcinogenicity and hormone studies with the tissue-selective estrogen receptor modulator bazadoxifene

    Journal of Cellular Physiology

    Volume 228, Issue 4, April 2013, Pages: 724–733, David J. Wright, J. Nicole Earnhardt, Richard Perry, Steven Bailey, Barry Komm, Daniel R. Minck and Mark A. Cukierski

    Version of Record online : 20 DEC 2012, DOI: 10.1002/jcp.24219

    Corrected by:

    Erratum: Carcinogenicity and Hormone Studies with the Tissue-Selective Estrogen Receptor Modulator Bazedoxifene

    Vol. 229, Issue 1, 126, Version of Record online: 23 SEP 2013

  12. A Network Meta-Analysis on the Short-Term Efficacy and Adverse Events of Different Anti-Osteoporosis Drugs for the Treatment of Postmenopausal Osteoporosis

    Journal of Cellular Biochemistry

    Accepted manuscript online: 11 DEC 2017, Gui-Feng Liu, Zong-Qiang Wang, Lin Liu, Bu-Tian Zhang, Ying-Ying Miao and Shao-Nan Yu

    DOI: 10.1002/jcb.26550

  13. You have free access to this content
    ASBMR 30th Annual Meeting M001–M507

    Journal of Bone and Mineral Research

    Volume 23, Issue S1, 13 August 2008, Pages: S374–S505,

    Version of Record online : 16 JUN 2011, DOI: 10.1002/jbmr.5650231306

  14. Evolution of the tissue selective estrogen complex (TSEC)

    Journal of Cellular Physiology

    Volume 228, Issue 7, July 2013, Pages: 1423–1427, Barry S. Komm and Sebastian Mirkin

    Version of Record online : 21 MAR 2013, DOI: 10.1002/jcp.24324

  15. Selective estrogen receptor modulators decrease the production of interleukin-6 and interferon-γ-inducible protein-10 by astrocytes exposed to inflammatory challenge in vitro

    Glia

    Volume 58, Issue 1, 1 January 2010, Pages: 93–102, M. Cerciat, M. Unkila, L. M. Garcia-Segura and M.-A. Arevalo

    Version of Record online : 16 JUN 2009, DOI: 10.1002/glia.20904

  16. You have free access to this content
    ASBMR 31st Annual Meeting FR0001–FR0464

    Journal of Bone and Mineral Research

    Volume 24, Issue S1, 2009, Pages: S94–S149,

    Version of Record online : 16 JUN 2011, DOI: 10.1002/jbmr.5650241302

  17. You have free access to this content
    Selective Oestrogen Receptor Modulators Decrease the Inflammatory Response of Glial Cells

    Journal of Neuroendocrinology

    Volume 24, Issue 1, January 2012, Pages: 183–190, M. A. Arevalo, Y. Diz-Chaves, M. Santos-Galindo, M. J. Bellini and L. M. Garcia-Segura

    Version of Record online : 20 DEC 2011, DOI: 10.1111/j.1365-2826.2011.02156.x

  18. You have free access to this content
    ASBMR 25th Annual Meeting SU001–SU482

    Journal of Bone and Mineral Research

    Volume 18, Issue S1, 2003, Pages: S175–S285,

    Version of Record online : 16 JUN 2011, DOI: 10.1002/jbmr.5650181305

  19. You have free access to this content
    Effect of alendronate for reducing fracture by FRAX score and femoral neck bone mineral density: The fracture intervention trial

    Journal of Bone and Mineral Research

    Volume 27, Issue 8, August 2012, Pages: 1804–1810, Meghan G Donaldson, Lisa Palermo, Kristine E Ensrud, Marc C Hochberg, John T Schousboe and Steven R Cummings

    Version of Record online : 17 JUL 2012, DOI: 10.1002/jbmr.1625

  20. You have free access to this content
    ASBMR 29th Annual Meeting

    Journal of Bone and Mineral Research

    Volume 22, Issue S1, September 2007, Pages: s452–s500,

    Version of Record online : 4 MAR 2010, DOI: 10.1002/jbmr.5650221411